By developing new capabilities in near-patient diagnosis, monitoring and health management, Alere gives decision-makers the tools they need to make informed health care choices. The result? We’re empowering people by putting them on the path to better health.
CLIA Waived Alere INRatio® 2 PT/INR Monitoring System
This CLIA Waived system for anticoagulation monitoring helps physicians monitor their patients’ warfarin therapy • Two levels of on board quality controls • Individually wrapped strips, no refrigeration required • Small sample size, one unmeasured drop of blood
CLIA Waived Alere Cholestech LDX® System
The CLIA Waived system provides complete lipid profile plus glucose testing and gives patients an advantage in CVD prevention and management • Rapid results in just 5 minutes enables face- to-face patient counseling • Fingerstick sampling: less painful and time consuming • Small sample size (40uL): easy to obtain
CLIA Waived Alere Triage® Meter
This CLIA Waived (for whole blood) test is a rapid, quantitative test for the measurement of BNP to aid in the diagnosis and assessment of heart failure • Test results are available in approximately 15 minutes (just two minutes of hands-on time) • Allows you to immediately consult with your patient on test results • Improve workflow and scheduling in your office
CLIA Waived AlereTM hCG Test
Our line of hCG products provide qualitative determination of human chorionic gonadotropin (hCG) in urine or serum for early detection of pregnancy • Flexibility to meet your testing needs with a variety of options • Streamline your process with simple testing methods • Improve patient care with rapid and accurate results in just minutes
CLIA Waived BinaxNOW® Influenza A & B & BinaxNOW® RSV
• One Sample: NP Swab, nasal wash • Two Tests: Influenza A & B and RSV • Three Results: Reimbursement for 3 tests1 • Fast: Results in 15 minutes • Onboard extraction: no extra steps • Sample types: nasopharyngeal swab, nasal wash specimens and nasal swab2
CLIA Waived Clearview® COMPLETE HIV 1/2 & Clearview® HIV 1/2 STAT-PAK®
• Fast: Results in 15 minutes or less3 • Accurate: 99.7% Sensitivity / 99.9% Specificity • Simple: Easy procedure & small sample size
CLIA Waived Clearview® Strep A Exact II Dipstick Test
• CLIA Waived • Results in 5 minutes • 97% Sensitivity / 95% Specificity
CLIA Waived NEW PRODUCT! AlereTM Influenza A & B Test
This CLIA waived test provides a simple, rapid method as an aid in the differential diagnosis of influenza A & B using nasal swab specimens • Results in 10 minutes • Nasal swab sample • Dual reimbursement1
CLIA Waived NEW PRODUCT! Alere HemoPoint® H2 Meter
This CLIA Waived meter provides a fast, reliable measurement of an individual’s hemoglobin level to help manage anemia and other red blood cell disorders • Rapid results in less than a minute enables face-to-face counseling with patients • Advanced microcuvette technology minimizes blood contamination • Easy to use sampling technique minimizes training time
CLIA Waived NEW PRODUCT! Afinion® AS100 Analyzer System
A new concept in point-of-care, a multiassay analyzer system that tests for HbA1c (CLIA Waived) and ACR. The system is designed to enable on-the-spot testing, with small sample size collected from fingerstick, venous whole blood, or urine sample (ACR) • Multiple analytes on one instrument • Short assay times (HbA1c: 3 minutes, ACR: 5 minutes) • Easy sample collection • Accurate and reliable results
For more information, contact your Alere Representative or Authorized Distributor.
1. Actual reimbursement may vary. 2. Nasal swabs cleared for use with the BinaxNOW® Influenza A & B test only. 3. See product insert under test procedure for full details.
© 2012 Alere. All rights reserved. The Alere Logo, Alere, Afinion, BinaxNOW, Cholestech LDX, Clearview, INRatio and Triage are trademarks of the Alere group of companies. HemoPoint is a trademark of Stanbio Laboratory LLP under license. PN: 2000159-01 3/12
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31